To add to your point about expensive failures, this weekend it was announced that Tome Biosciences is going belly up. This is only a few years after being found

To add to your point about expensive failures, this weekend it was announced that Tome Biosciences is going belly up. This is only a few years after being founded on some very promising research out of MIT. That’s $213M in investor money gone. https://www.statnews.com/2024/08/22/tome-biosciences-gene-editing-biotech-floundering/ https://www.statnews.com/2024/08/22/tome-biosciences-gene-ed...